//
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Heart failure with preserved ejection fraction: from mechanisms to therapies
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification
Nitrosative stress drives heart failure with preserved ejection fraction
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure